Modified docetaxel, cisplatin and fluorouracil therapy as the first-line treatment for patients with recurrent/metastatic squamous cell carcinoma of the head and neck cancer: a retrospective study


Demirci N. S. , AKSOY S., ÖZDEMİR N., Erdem G. U. , Ozcelik M., Tanrikulu E., ...More

CURRENT MEDICAL RESEARCH AND OPINION, vol.33, no.3, pp.401-407, 2017 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 33 Issue: 3
  • Publication Date: 2017
  • Doi Number: 10.1080/03007995.2016.1257984
  • Title of Journal : CURRENT MEDICAL RESEARCH AND OPINION
  • Page Numbers: pp.401-407

Abstract

Aim: Modified docetaxel, cisplatin, and 5-fluorouracil (mDCF) therapy has been shown to be a well tolerated and highly effective regimen for metastatic gastric carcinoma. Herein we investigated the effectiveness of the mDCF combination as the first-line treatment in patients with recurrent/metastatic squamous cell carcinoma of the head and neck (HNSCC).